Pharsight

Drugs that contain Estradiol Acetate

1. Femring patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5855906 MILLICENT Intravaginal drug delivery devices for the administration of 17β-oestradiol precursors
Dec, 2015

(8 years ago)

Market Authorisation Date: 20 March, 2003

Treatment: Method of releasing 17-beta oestradiol precursor in a substantially zero order pattern for at least three weeks

Dosage: INSERT, EXTENDED RELEASE;VAGINAL

More Information on Dosage

FEMRING family patents

Family Patents

2. Femtrace patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7799771 APIL Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
Dec, 2021

(2 years ago)

US6962908 APIL Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
Dec, 2021

(2 years ago)

US7572779 APIL Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
Oct, 2025

(1 year, 4 months from now)

Market Authorisation Date: 20 August, 2004

Treatment: Treatment of moderate to severe vasomotor symptoms associated with menopause

Dosage: TABLET;ORAL

More Information on Dosage

FEMTRACE family patents

Family Patents